203 related articles for article (PubMed ID: 805176)
1. Immunosuppression induced in vitro by mastocytoma tumor cells and cell-free extracts.
Kamo I; Patel C; Kateley J; Friedman H
J Immunol; 1975 Jun; 114(6):1749-56. PubMed ID: 805176
[TBL] [Abstract][Full Text] [Related]
2. Restoration of in vitro immune responsiveness of mastocytoma-suppressed splenocytes by activated T cells.
Kamo I; Patel C; Patel N; Friedman H
J Immunol; 1975 Aug; 115(2):382-6. PubMed ID: 807635
[TBL] [Abstract][Full Text] [Related]
3. Suppression of antibody responses in allogeneic mice by products of lymphoid tissue. II. Lack of antigenic specificity and immunogenetic requirements of allogeneic suppressive factor (ASF).
Yonkosky D; Buffett RF; Bennett M
J Immunol; 1976 Jun; 116(6):1695-703. PubMed ID: 58047
[TBL] [Abstract][Full Text] [Related]
4. Mastocytoma-induced suppression of in vitro antibody formation.
Kamo I; Kateley J; Freidman H
Proc Soc Exp Biol Med; 1975 Mar; 148(3):883-6. PubMed ID: 805435
[TBL] [Abstract][Full Text] [Related]
5. Differential immunosuppressive effects of ascites fluid from mastocytoma-bearing mice on primary vs secondary immunocyte responses.
Kamo I; Friedman H
J Immunol; 1978 Feb; 120(2):558-62. PubMed ID: 413868
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the immune response in vitro and in vivo by splenocytes from tumor-bearing mice.
Specter SC; Kamo I; Friedman H
Adv Exp Med Biol; 1976; 66():457-63. PubMed ID: 817575
[TBL] [Abstract][Full Text] [Related]
7. The potentiality of antibody-producing cells. I Bispecific cell occurrence in double stimulated cultures of syngeneic or allogeneic spleen cells of the mouse.
Couderc J; Bleux C; Birrien JL; Liacopoulos P
Immunology; 1975 Oct; 29(4):653-64. PubMed ID: 1102444
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of mastocytoma-mediated suppression of lymphocyte reactivity.
DeLustro F; Argyris BF
J Immunol; 1976 Dec; 117(6):2073-80. PubMed ID: 136473
[TBL] [Abstract][Full Text] [Related]
9. In vivo immune response suppression by the supernatant from concanavalin A-activated spleen cells.
Reinertsen JL; Steinberg AD
J Immunol; 1977 Jul; 119(1):217-22. PubMed ID: 326957
[TBL] [Abstract][Full Text] [Related]
10. In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.
Takei F; Levy JG; Kilburn DG
J Immunol; 1976 Feb; 116(2):288-93. PubMed ID: 814160
[TBL] [Abstract][Full Text] [Related]
11. The relation between the T cells responsible for cell-mediated cytotoxic killing of mastocytoma cells and the helper-cell effect.
Igarashi T; Okada M; Kishimoto S; Yamamura Y
Immunology; 1975 Jan; 28(1):37-47. PubMed ID: 803916
[TBL] [Abstract][Full Text] [Related]
12. Suppression of antibody responses in allogeneic mice by products of lymphoid tissue. I. Allogeneic suppressive factor (ASF) from spleens repopulated with thymus cells.
Yonkosky D; Buffett RF; Bennett M
J Immunol; 1976 Jun; 116(6):1688-94. PubMed ID: 58046
[TBL] [Abstract][Full Text] [Related]
13. "Nonspecific" immunoenhancing T cells in tumor-bearing mice include anti-idiotypic subsets.
Behforouz N; Eardley DD; Cerny J
J Immunol; 1983 Nov; 131(5):2576-9. PubMed ID: 6226744
[TBL] [Abstract][Full Text] [Related]
14. Characterization of suppressor cells in mice bearing syngeneic mastocytoma.
Takei F; Levy JG; Kilburn DG
J Immunol; 1977 Feb; 118(2):412-7. PubMed ID: 65423
[TBL] [Abstract][Full Text] [Related]
15. Tumor-induced immunosuppression.
Friedman H; Specter S; Watanabe M; Pan SH
Am J Pathol; 1978 Nov; 93(2):499-514. PubMed ID: 102206
[TBL] [Abstract][Full Text] [Related]
16. Myeloma-induced immunosuppression: a multistep mechanism.
Katzmann JA
J Immunol; 1978 Oct; 121(4):1405-9. PubMed ID: 701801
[TBL] [Abstract][Full Text] [Related]
17. Suppression of the antibody response to SRBC with F(ab') 2 and IgG in vitro.
Wason WM; Fitch FW
J Immunol; 1973 May; 110(5):1427-9. PubMed ID: 4572635
[No Abstract] [Full Text] [Related]
18. [Effects of humoral factors of the mastocytoma P815 cells on the formation of allospecific killers in mixed culture of lymphocytes and their cytotoxic activity].
Medvedev AE; Dostman U; Flegel' A
Biull Eksp Biol Med; 1989 Aug; 108(8):224-6. PubMed ID: 2529921
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.
Inge TH; Hoover SK; Susskind BM; Barrett SK; Bear HD
Cancer Res; 1992 Mar; 52(6):1386-92. PubMed ID: 1531782
[TBL] [Abstract][Full Text] [Related]
20. Non-specific suppression of the initiation of the immune response to a heterologous immunogen by supernatants from specifically stimulated, primed lymphoid cells.
Douglas GN; Rubin AS
Immunology; 1977 May; 32(5):669-79. PubMed ID: 324897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
